India Blood Gas and Cardiac Biomarker POC Analyzer Market is Driven by Rising Investment in Healthcare, Increasing Number of Cardiac Patients and Growth in Elderly Population: Ken Research

“Rising importance of affordable healthcare facilities and growth in number of life style related disease patients in the country has driven the blood gas and cardiac biomarker POC analyzer sector in India”.

Analysts at Ken Research in their latest publication “India Blood Gas and Cardiac Biomarker POC Analyzer Market Outlook to 2025-By Product (Device and Reagent), By Device Type (Medium to High Workload and Single Test Analyzer Device), By Region (Tier 1, Tier 2 and Tier 3) and By End User (Hospital, Clinics and Small Health Setup and Diagnostic Labs)” observed that the market in India is in growth stage and it will witness further growth owing to factors such as rising healthcare expenditure, increase in number of  healthcare establishments and increasing penetration of medical insurance across the country. The blood gas POC analyzer market is expected to register a positive CAGR of 17.2% while the cardiac biomarker POC analyzer market is expected to register a positive CAGR of 19.3% in terms of revenue during the forecast period FY’2019-FY’2025F.

Rise in Chronic Diseases and Lifestyle Changes: Lifestyle related changes have resulted in growing number of patients with cardiac disorders and increase in patients with acute problems. This has led to positive growth in blood gas and cardiac biomarker POC sector as patients are required to be screened regularly for prognosis and diagnosis of the disease. In addition, technological interventions to market low cost analyzers have resulted in the industry witnessing growth in revenue coming from Tier-2 and Tier-3 market.

Growing Healthcare Expenditure: The public healthcare expenditure stood at INR 213,719.6 Crore in FY’2018. The government of India has been taking regular initiatives to increase this expenditure to level of 2.5% of country’s GDP by 2025 in regards to its National Health Policy. Increase in healthcare expenditure has led to successive Greenfield and Brownfield growth in hospital sector. Consequentially, this has led to increase in revenue of the blood gas and cardiac biomarker POC analyzer industry as new capital systems, upgraded with latest technology are being installed at various healthcare facilities.

Growing Elderly Population: Rising elderly population has led to higher demand for various types of medical procedures which has complemented the number of tests for blood gas and cardiac parameters. The elderly population of India stood at 114.4 million in FY’2014 and increased to 132.0 million in FY’2019. Inclusion of more parameters for creating a comprehensive test menu has aided in increase in increase in volume of reagent being utilized in the industry which has led to higher demand for automated higher workload systems.

Key Segments Covered:-

Blood Gas POC Analyzer Market:

By Type of Product (Reagent and Device)

By Type of Device (Medium to High Workload Device and Single Test Analyzer Device)

By Region (Tier-1, Tier-2 and Tier-3)

By End User (Hospital, Clinics and Small Health Setup and Diagnostic Lab)

Cardiac Biomarker POC Analyzer Market:

By Type of Product (Reagent and Device)

By Type of Device (Semi-Automated Small Portable System and Fully-Automated High End System)

By Type of Cardiac Biomarker (Troponin, CKMB, NTproBNP, D-Dimer, CRP, Procalcitonin and Others)

By Region (Tier-1, Tier-2 and Tier-3)

By End User (Hospital, Clinics and Small Health Setup and Diagnostic Lab)

Key Target Audience:-

Blood Gas Device Manufacturers

Blood Gas Reagent Manufacturers

Blood Gas Device Importers

Government Agencies

Cardiac Biomarker Analyzer Manufacturers

Cardiac Biomarker Reagent Manufacturers

Cardiac Biomarker Device Importers

Blood Gas and Cardiac Biomarker Analyzer Distributors

Time Period Captured in the Report:-

Historical Period: FY’2014- FY’2019

Forecast Period: FY’2020F– FY’2025F

Companies Covered:-

Blood Gas POC Analyzer:

Radiometer

Siemens Healthcare

Instrumentation Laboratory

Abbott Healthcare

Roche Diagnostics

OPTI Medical System

Guangzhou Wondfo Biotech

Cardiac Biomarker POC Analyzer:-

Biomerieux

Quidel Diagnostics

Abbott Healthcare

Guangzhou Wondfo Biotech

Radiometer

Roche Diagnostics

Diasys Diagnostics

Boditec Med Inc

Agappe Diagnostics

Siemens Healthcare

For more information on the research report, refer to below links:-

India Blood Gas and Cardiac Biomarker POC Analyzer Market

Related Reports:-

India POCT Market Outlook to 2023 - By Major Devices (Blood Glucose Testing Kits, Infectious Disease Testing Kits, Blood Gas Electrolytes, Pregnancy and Fertility Testing Kits, Cardio Metabolic Monitoring, Anticoagulant Management, Cholesterol Testing Kits and Others), By End Users (Hospitals & Clinics, Consumers/ Individuals, Diagnostic Labs, Home Healthcare and Others), By Distribution Channel (Distributors and Direct Sales), By Consumables and Instruments and By Region

Global Point-Of-Care Testing (POCT) Devices Market Status (2015-2019) And Forecast (2020-2024) By Region, Product Type & End-Use

Europe POCT Devices Market Outlook to 2022 - by Geography (Western Europe & Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients)

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249